Health Care - Spark Newswire

1 minute read

ANI Pharmaceuticals Sees FY23 Adjusted EPS of $2.09-$2.59 Vs. Consensus Of $2.62; Forecasts Revenues Of $360M-$385M Vs. $352.49M Estimate

Today, 6:16 AM

2023 Cortrophin specific revenue guidance is between $80.0 million to $90.0 million, representing 92% to 116% growth as compared to $41.7 million recognized in

ANIP

2 minute read

Florida Republicans Propose Six-Week Abortion Ban, Further Narrowing Abortion Access

By Vandana Singh

Today, 6:16 AM

Florida Republicans introduced a bill to ban abortion after six weeks of pregnancy, offering exemptions for victims of rape and incest cases.

WBA

1 minute read

CEL-SCI’s Lead Head & Neck Cancer Candidate Shows 43% Survival Extension

By Vandana Singh

Today, 6:16 AM

CEL-SCI Corporation (NASDAQ:CVM) reported new data from its pivotal Phase 3 study of Multikine (Leukocyte Interleukin) in newly diagnosed locally advanced…

CVM

1 minute read

FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson, Atrophy Program

By Vandana Singh

Today, 6:16 AM

The FDA lifted the full Clinical Hold on Inhibikase Therapeutics Inc’s (NASDAQ:IKT) IkT-148009, the company’s c-Abl inhibitor, in Multiple System…

IKT

1 minute read

RenovoRx’s Targeted Pancreatic Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care

By Vandana Singh

Today, 6:16 AM

RNXT

1 minute read

Mesoblast’s Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids

By Vandana Singh

Today, 6:16 AM

Mesoblast Ltd (NASDAQ:MESO) rallied after the FDA agreed to review the company’s lead drug candidate, remestemcel-L, on a priority basis, more…

MESO

1 minute read

Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births

By Vandana Singh

Today, 6:16 AM

Privately held-Covis Pharma, the maker of Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth, said…

IBB

1 minute read

Health Care ETFs Have Lost In The Last Month – These Top Pharma Stocks Are The Reason

By Vandana Singh

Today, 6:16 AM

The Health Care Select Sector SPDR Fund (NYSE:XLV), heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies…

ABBV

1 minute read

Analyst Downgrades Gossamer Bio As Merck’s Sotatercept Might Overshadow Seralutinib’s Success

By Vandana Singh

Today, 6:16 AM

Raymond James has downgraded Gossamer Bio Inc (NASDAQ:GOSS) to Market Perform from Outperform following the publication of sotatercept’s Phase 3 data in NEJM. …

GOSS

2 minute read

FDA’s Regulatory Delay is The Reason For Novavax, Lucira Health’s Failure: WSJ Report

By Vandana Singh

Today, 6:16 AM

Failures of Covid vaccine maker Novavax Inc (NASDAQ: NVAX) and diagnostic start-up Lucira Health Inc (NASDAQ: LHDX) show that companies often succeed or fail, owing to the whims of the government.&nb

LHDX